Could a breast cancer drug ease fibroid pain?

NCT ID NCT06143631

First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 20 times

Summary

This study tests whether letrozole, a drug currently used for breast cancer, can reduce symptoms like heavy bleeding and pelvic pain caused by uterine fibroids. About 140 premenopausal women will receive either letrozole or a placebo for 12 weeks. The goal is to see if the drug improves quality of life and shrinks fibroids.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBROID UTERUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Duke University

    RECRUITING

    Durham, North Carolina, 27710, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of California, Los Angeles

    RECRUITING

    Los Angeles, California, 90095, United States

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94115, United States

    Contact

    Contact Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••

  • University of Mississippi Medical Center

    RECRUITING

    Jackson, Mississippi, 39216, United States

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.